AbbVie (DE:4AB)
XETRA:4AB
Holding DE:4AB?
Track your performance easily

AbbVie (4AB) Technical Analysis

15 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is 3.77, suggesting AbbVie is a Buy.
AbbVie’s (4AB) 20-Day exponential moving average is 172.68, while AbbVie’s (4AB) share price is €176.52, making it a Buy.
AbbVie’s (4AB) 50-Day exponential moving average is 166.01, while AbbVie’s (4AB) share price is €176.52, making it a Buy.

AbbVie (4AB) Pivot Points

Aug 25, 2024, 11:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
174.55
175.31
175.89
176.65
177.23
177.99
178.57
Fibonacci
175.31
175.82
176.13
176.65
177.16
177.47
177.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Aug 25, 2024, 11:22 AM
Period
Simple
Exponential
MA5
176.46Sell
176.09Buy
MA10
175.50Buy
175.27Buy
MA20
173.84Buy
172.68Buy
MA50
163.99Buy
166.01Buy
MA100
157.14Buy
160.37Buy
MA200
152.12Buy
152.67Buy
AbbVie’s (4AB) 10-Day exponential moving average is 175.27, while AbbVie’s (4AB) share price is €176.52, making it a Buy.
AbbVie’s (4AB) 100-Day exponential moving average is 160.37, while AbbVie’s (4AB) share price is €176.52, making it a Buy.
AbbVie’s (4AB) stock price is €176.52 and AbbVie’s (4AB) 50-day simple moving average is 163.99, creating a Buy signal.
AbbVie’s (4AB) stock price is €176.52 and AbbVie’s (4AB) 100-day simple moving average is 157.14, creating a Buy signal.
AbbVie’s (4AB) stock price is €176.52 and AbbVie’s (4AB) 200-day simple moving average is 152.12, creating a Buy signal.

AbbVie (4AB) Technical Indicators

Aug 25, 2024, 11:22 AM
Name
Value
Implied Action
RSI (14)
65.24
Neutral
STOCH (9,6)
55.46
Neutral
STOCHRSI (14)
77.84
Neutral
MACD (12,26)
3.77
Buy
ADX (14)
33.36
Neutral
Williams %R
-27.20
Buy
CCI (14)
94.57
Neutral
ATR (14)
2.95
-
Ultimate Oscillator
41.10
Neutral
ROC
4.05
Buy
AbbVie’s (4AB) Relative Strength Index (RSI) is 65.24, creating a Neutral signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 33.36, creating a Neutral signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is 94.57, creating a Neutral signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is 4.05, creating a Buy signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Strong Buy.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 65.24, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is 3.77, which suggests 4AB is a Buy.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 176.46, which suggests 4AB is a Sell.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 173.84, which suggests 4AB is a Buy.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 163.99, which suggests 4AB is a Buy.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 152.12, which suggests 4AB is a Buy.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -27.20, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is 94.57, which suggests 4AB is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis